La Trobe

Global protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenografts

Download (285.26 kB)
Version 3 2024-11-25, 04:59
Version 2 2023-03-29, 01:59
Version 1 2021-08-13, 01:35
journal contribution
posted on 2024-11-25, 04:59 authored by Sze LeeSze Lee, H Ji, David GreeningDavid Greening, RWH Speirs, Angela RigopoulosAngela Rigopoulos, V Pillay, C Murone, A Vitali, K Stühler, Terrance JohnsTerrance Johns, GA Corner, John MariadasonJohn Mariadason, Richard SimpsonRichard Simpson, Andrew ScottAndrew Scott

No description supplied 

Funding

Funding was provided by the Australian National Health and Medical Research Council under Program Grant #487922, and NHMRC Project Grant #234709. We acknowledge the NHMRC-funded Australian Proteomics Computational Facility (APCF) under Enabling Grant #381413. This work was supported, in part, by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. We acknowledge the Australian Cancer Research Foundation for providing funds to purchase the Orbitrap (TM) mass spectrometer. Andrew M. Scott and Terrance G. Johns are inventors on patents for mAb806.

History

Publication Date

2013-10-01

Journal

Growth Factors

Volume

31

Issue

5

Pagination

(p. 154-164)

Publisher

Taylor & Francis

ISSN

0897-7194

Rights Statement

© The Authors 2013 This is an Accepted Manuscript version of the following article, accepted for publication in Growth Factors. Sze Ting Lee, Hong Ji, David W. Greening, Robert W. H. Speirs, Angela Rigopoulos, Vinochani Pillay, Carmel Murone, Angela Vitali, Kai Stühler, Terrance G. Johns, Georgia A. Corner, John M. Mariadason, Richard J. Simpson & Andrew M. Scott (2013) Global protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenografts, Growth Factors, 31:5, 154-164, DOI: 10.3109/08977194.2013.824435. It is deposited under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Usage metrics

    Journal Articles

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC